Filing Overview
Surrozen, Inc. filed a Form 8-K dated June 5, 2024, reporting the results of its 2024 Annual Meeting of Stockholders. The filing was signed on June 7, 2024. A total of 3,198,786 common shares were entitled to vote as of the April 10, 2024 record date, and 1,808,279 shares were represented at the meeting.
Meeting Results
Election of Directors
Stockholders elected all three Class III director nominees to serve until the 2027 Annual Meeting or until their successors are elected and qualified.
| Nominee | For | Withheld | Broker Non-Votes |
|---|---|---|---|
| Christopher Y. Chai | 1,267,311 | 147,380 | 393,588 |
| Mary Haak-Frendscho, Ph.D. | 1,410,102 | 4,589 | 393,588 |
| Craig Parker | 1,409,464 | 5,227 | 393,588 |
Independent Auditor
Stockholders ratified the appointment of Ernst & Young LLP as Surrozen’s independent registered public accounting firm for the fiscal year ending December 31, 2024.
| For | Against | Abstain |
|---|---|---|
| 1,803,744 | 416 | 4,119 |
Financial Metrics and Liquidity
This filing does not provide revenue, profit, cash flow, margin, debt, liquidity, guidance, or other operating and financial metrics.
Material Changes, Outlook, and Risks
The filing reports no operating, financial, strategic, or risk-related changes. No management outlook or guidance was provided. No other matters were submitted to a stockholder vote.
Key Facts to Verify
- Confirm the election of the three Class III directors and their intended terms through the 2027 Annual Meeting.
- Confirm Ernst & Young LLP’s ratification as auditor for fiscal year 2024.
- Review subsequent filings for financial results, financing activity, liquidity runway, clinical developments, and any additional corporate governance changes.